{
  "id": 6604143,
  "title": "Major Novartis shareholder calls for board shake-up after drug trial setbacks",
  "url": "https://urgent.news/2026/09/10/major-novartis-shareholder-calls-for-board-shake-up-after-drug-trial",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-10T15:23:00.000Z",
  "source": {
    "name": "Straits Times Business",
    "slug": "straits-times-business",
    "url": "https://www.straitstimes.com/business/major-novartis-shareholder-calls-for-board-shake-up-after-drug-trial-setbacks"
  },
  "original_language": "en",
  "account": "A major Novartis shareholder has called for a major overhaul of the company's board after two consecutive drug trial failures led to a record drop in the company's shares. David Samra, managing director at Artisan Partners and co-founder of International Value Group, argued that the board needs to step up oversight of acquisitions. The latest setbacks, following a failed late-stage study of a drug acquired through a US$12 billion takeover and disappointing results from a heart drug, sent Novartis' shares plummeting over 10 percent. Samra did not blame CEO Vas Narasimhan for the share price fall, praising his leadership despite a tough global environment. However, he criticized the board for its poor track record of M&A deals, which have destroyed value. Samra also urged the board to revise the company's compensation structure to more accurately reflect economic outcomes.",
  "summary": "David Samra does not fault CEO Vas Narasimhan and says he has done \"a very good job\".",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Gulf Times Business",
        "title": "Major Novartis shareholder calls for board shakeup after drug trial setbacks",
        "url": "https://urgent.news/2026/09/09/major-novartis-shareholder-calls-for-board-shakeup-after-drug-trial",
        "published": "2026-09-09T21:00:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}